Pair Name | Sophocarpine, Oxaliplatin | ||
Phytochemical Name | Sophocarpine (PubChem CID: 115269 ) | ||
Anticancer drug Name | Oxaliplatin (PubChem CID: 9887053 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Sophocarpine, Oxaliplatin | |||
Disease Info | [ICD-11: 2B90] | Colon cancer | Investigative | |
Biological Phenomena | Inhibition-->Epithelial-mesenchymal transition | |||
Gene Regulation | Up-regulation | Expression | CDH1 | hsa999 |
Down-regulation | Expression | CDH2 | hsa1000 | |
Down-regulation | Expression | VIM | hsa7431 | |
In Vitro Model | LoVo | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0399 |
In Vivo Model | Liver metastasis nude mouse models (n = 40) were prepared by the injection of LoVo cells suspended in PBS into the center point of the spleen using a 31-gauge needle. | |||
Result | Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo |
No. | Title | Href |
---|---|---|
1 | Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol. 2021 Jun;394(6):1263-1274. doi: 10.1007/s00210-020-02032-8. | Click |